Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis

Huntington’s Disease (HD) is a severely debilitating neurodegenerative disorder in which sufferers exhibit different combinations of movement disorders, dementia, and behavioral or psychiatric abnormalities. The disorder is a result of a trinucleotide repeat expansion mutation that is inherited in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Van de Roovaart, Hannah J., Nguyen, Nguyen, Veenstra, Timothy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674993/
https://www.ncbi.nlm.nih.gov/pubmed/38004378
http://dx.doi.org/10.3390/ph16111513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674993/
https://www.ncbi.nlm.nih.gov/pubmed/38004378
http://dx.doi.org/10.3390/ph16111513

Ejemplares similares